Aptus Capital Advisors, LLC
Institutional investor · Portfolio as of Q2 2021
Top Holdings573 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
APTUS DEFINED RISK ETF | 9M | $266.1M | 7.8% | $22.91 | +11.45% | 10 qtrssince 2019-Q1 | Increased 62 |
ISHARES | 6.2M | $162.8M | 4.8% | $23.99 | +1.90% | 10 qtrssince 2019-Q1 | Increased 65 |
INVESCO QQQ TRUST SERIES 1 CL USD INC | 370,000 | $131.1M | 3.8% | — | — | — | Increased — |
APTUS DRAWDOWN MANAGED EQUITY ETF | 3.2M | $128.6M | 3.8% | $29.79 | +29.96% | 10 qtrssince 2019-Q1 | Increased 57 |
ETF SER SOLUTIONS | 4.3M | $128.5M | 3.8% | $23.93 | +21.48% | 8 qtrssince 2019-Q3 | Increased 58 |
MICROSOFT CORP | 440,000 | $119.2M | 3.5% | — | — | — | Increased — |
ISHARES | 4.5M | $114.9M | 3.4% | $25.41 | -0.03% | 10 qtrssince 2019-Q1 | Increased 63 |
ISHARES | 4.2M | $110.5M | 3.2% | $23.61 | +1.03% | 5 qtrssince 2020-Q2 | Increased 63 |
ISHARES | 4.1M | $109.3M | 3.2% | $23.11 | +1.26% | 5 qtrssince 2020-Q2 | Increased 63 |
HEALTH CARE SELECT SECTOR SPDR | 800,000 | $100.8M | 2.9% | — | — | — | New — |
iShares iBonds Dec 2021 Term Co | 3.6M | $90M | 2.6% | $24.88 | -0.42% | 10 qtrssince 2019-Q1 | Increased 58 |
CONSUMER DISCRETIONARY SELT | 500,000 | $89.3M | 2.6% | — | — | — | New — |
APPLE INC | 610,000 | $83.5M | 2.4% | — | — | — | Increased — |
INDUSTRIAL SELECT SECT SPDR | 800,000 | $81.9M | 2.4% | — | — | — | New — |
META PLATFORMS INC-CLASS A | 210,000 | $73M | 2.1% | — | — | — | Increased — |
OPUS SMALL CAP VALUE ETF | 2.1M | $69.7M | 2.0% | $24.65 | +24.36% | 10 qtrssince 2019-Q1 | Increased 55 |
ISHARES IBOXX INVESTMENT GRA | 500,000 | $67.2M | 2.0% | — | — | — | New — |
SALESFORCE.COM INC | 260,000 | $63.5M | 1.9% | — | — | — | New — |
INVESCO | 2.9M | $61.1M | 1.8% | $21.15 | — | 9 qtrssince 2019-Q2 | Increased 53 |
ALPHABET INC-CL A | 24,000 | $58.6M | 1.7% | — | — | — | Increased — |
Aptus Capital Advisors, LLC manages $3.4B across 573 positions as of Q2 2021. Top holdings: DRSK (7.8%), IBDO (4.8%), QQQ (3.8%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3.5/5.0.
Active quarter - 76 new positions, 25 exits, 287 increased. Top move: IBDO (INCREASED, conviction 65). Portfolio: $3.4B across 573 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer